The present disclosure relates generally to apparatuses, systems, and methods that include anchors for medical devices. More specifically, the disclosure relates to apparatuses, systems, and methods that include anchors for chordae tendineae repair.
Leaflets of atrioventricular valves (mitral and tricuspid) are thin, diaphanous structures that rely on a system of long, thin, cord-like supports to maintain competence of the valve in the loaded condition. These supports, chordae tendineae, attach the papillary muscles to the valve leaflets.
Chordae tendineae can degenerate and stretch, which can result in leaflet prolapse. As a result, the leaflet(s) can misalign under systolic loading. An open surgical procedure for chordae tendineae is highly invasive and carries with it a high morbidity and mortality risk. Thus, delivery and implantation of artificial chordae tendineae(s) in chordae tendineae replacement or repair without using an open surgical procedure (or a transapical or transatrial delivery approach) can reduce morbidity and mortality risk.
According to one example (“Example 1”), a tubular member having a proximal end and a distal end; at least one wire arranged through the tubular member to form: a plurality of anchors extending from the distal end of the tubular member, each anchor defining a curve extending in a direction toward the proximal end, and an eyelet extending from the proximal end; and a tissue piercing element extending from the proximal end of the tubular member and arranged adjacent to the plurality of anchors.
According to another example (“Example 2”), further to the tissue anchor of Example 1, the at least one wire includes at least two wires arranged through the tubular member, and the at least two wires overlap to form the eyelet.
According to another example (“Example 3”), further to the tissue anchor of Example 2, the at least two wires form the plurality of anchors and the plurality of anchors includes at least four anchors.
According to another example (“Example 4”), further to the tissue anchor of any one of Examples 1-2, the tubular member includes a plurality of lumens extending between the proximal end and the distal end, and the lumens are configured to maintain an arrangement of the at least one wire.
According to another example (“Example 5”), further to the tissue anchor of any one of Examples 1-4, the tissue piercing element includes a longitudinal portion and a depth indicator configured to provide tactile feedback to a physician embedding of the plurality of anchors within tissue.
According to another example (“Example 6”), further to the tissue anchor of Example 5, the depth indicator includes a spacer and a biasing member arranged about the longitudinal portion of the tissue piercing element, the spacer is configured to contact tissue and urge the biasing member toward the distal end of the tubular member, the degree of which is configured to indicate the extent to which the plurality of anchors extend within the tissue.
According to another example (“Example 7”), further to the tissue anchor of any one of Examples 1-6, the tubular member comprises at least one of PEEK and stainless steel.
According to another example (“Example 8”), further to the tissue anchor of any one of Examples 1-7, the tissue anchor also includes a flexible cord arranged through the eyelet for coupling the tissue anchor to tissue.
According to another example (“Example 9”), further to the tissue anchor of any one of Examples 1-8, the tissue anchor also includes a location feedback mechanism arranged at the distal end of the tubular member and configured to indicate a slope or angle of a tissue wall.
According to another example (“Example 10”), a tissue anchor includes at least one wire arranged to form: an upper circular portion configured to interface with a flexible cord, one or more tissue piercing elements configured to engage a tissue surface and move between a first configuration in which the one or more tissue piercing elements are arranged substantially parallel to the tissue surface and a second configuration where the one or more tissue piercing elements are arranged non-parallel to the tissue surface, and an intermediate portion configured to move the one or more tissue piercing elements from the first configuration to the second configuration in response to a reduction in diameter of the middle portion.
According to another example (“Example 11”), further to the tissue anchor of Example 10, the middle portion is substantially oval in shape.
According to another example (“Example 12”), further to the tissue anchor of any one of Examples 10-11, the at least one wire includes a second circular portion and the one or more tissue piercing elements extend from the second circular portion.
According to another example (“Example 13”), further to the tissue anchor of any one of Examples 10-12, the tissue anchor also includes a delivery sheath configured to reduce the intermediate portion in diameter and unconstrain the intermediate portion allow movement of the one or more tissue piercing elements from the first configuration to the second configuration.
According to another example (“Example 14”), further to the tissue anchor of Example 13, the one or more tissue piercing elements are configured to grip the tissue surface in response to movement from the first configuration to the second configuration.
According to another example (“Example 15”), further to the tissue anchor of any one of Examples 10-14, the flexible cord is configured for coupling the tissue anchor to tissue.
According to one example (“Example 16”), a tissue anchor includes a cylindrical portion having a longitudinal axis, a proximal end and a distal end; and a plurality of anchors configured to secure the cylindrical portion under a tissue surface, each of the plurality of anchors including: a substantially linear section extending from the distal end of the cylindrical portion parallel to the longitudinal axis, and a curved section extending from the substantially linear section and configured to align with the substantially linear section relative to the longitudinal axis in a delivery configuration and curve radially outwardly relative to the longitudinal axis and toward the distal end of the cylindrical portion in a deployed configuration.
According to another example (“Example 17”), further to the tissue anchor of Example 16, the cylindrical portion includes one or more notches in an exterior surface of the cylindrical portion.
According to another example (“Example 18”), further to the tissue anchor of Example 17, the one or more notches are configured to facilitate flexibility of the cylindrical portion.
According to another example (“Example 19”), further to the tissue anchor of any one of Examples 16-18, the tissue anchor also includes a flexible cord arranged through an opening in the cylindrical portion configured for coupling the tissue anchor to tissue.
According to another example (“Example 20”), further to the tissue anchor of Example 19, the cylindrical portion includes an adjustment mechanism configured to adjust a length of the flexible cord.
According to one example (“Example 21”), a tissue anchor includes a first anchor section including a first curved section and a first tissue piercing element extending longitudinally from an interior surface of an apex the first curved section; a second anchor section including a second curved section and a second tissue piercing element extending longitudinally from an interior surface of an apex of the second curved section; a first transition section arranged between and extending perpendicular to the first anchor section and the second anchor section in a first plane; and a second transition section arranged between and extending perpendicular to the first anchor section and the second anchor section in a second plane.
According to another example (“Example 22”), further to the tissue anchor of Example 21, the first plane and the second plane are spaced apart from one another.
According to another example (“Example 23”), further to the tissue anchor of any one of Examples 21-22, at least one of the first transition section and the second transition defines a curve.
According to another example (“Example 24”), further to the tissue anchor of any one of Examples 21-23, the first anchor section, the second anchor section, the first transition section, and the second transition are configured to deploy to within a substantially common plane.
According to another example (“Example 25”), further to the tissue anchor of any one of Examples 21-24, the tissue anchor also includes a flexible cord coupled to at least one of the first anchor section, the second anchor section, the first transition section, and the second transition for coupling the tissue anchor to tissue.
According to one example (“Example 26”), a tissue anchor includes a cylindrical portion having a lumen, a proximal end and a distal end; a plurality of anchors extending from the lumen and radially outwardly relative to an exterior surface of the cylindrical portion; a ball arranged at or adjacent to the distal end of the cylindrical portion; and a flexible cord extending within the lumen of the cylindrical portion and coupled to the ball, the flexible cord being configured to withdraw the ball toward the proximal end and engage the plurality of anchors to alter a configuration of the plurality of anchors.
According to another example (“Example 27”), further to the tissue anchor of Example 26, the ball is configured to at least partially withdraw into the lumen to alter the configuration of the plurality of anchors.
According to one example (“Example 28”), a tissue anchor includes a cylindrical portion having a proximal end and a distal end; and an anchor element configured to secure the cylindrical portion to or under a tissue surface, the anchor element having a helical structure having a proximal end arranged at the distal end of the cylindrical portion and including a plurality of loops of increasing diameter from the proximal end of the helical structure to a distal end of the helical structure.
According to another example (“Example 29”), further to the tissue anchor of Example 28, the tissue anchor also includes one or more barbs arranged on an exterior surface of the helical structure.
According to another example (“Example 30”), further to the tissue anchor of any one of Examples 28-29, the tissue anchor also includes a flexible cord coupled to the cylindrical portion configured for coupling the tissue anchor to tissue.
According to one example (“Example 31”), a tissue anchor includes a cylindrical portion having a proximal end and a distal end; a plurality of substantially linear sections extending from the distal end of the cylindrical portion; and a plurality of helical anchors arranged at distal ends of each of the plurality of substantially linear sections configured to secure the cylindrical portion to a tissue wall.
According to another example (“Example 32”), further to the tissue anchor of Example 31, the tissue anchor also includes a flexible cord coupled to the cylindrical portion configured for coupling the tissue anchor to tissue.
According to one example (“Example 33”), a method for chordae tendineae repair includes: arranging a flexible cord through a leaflet and anchoring a first end of the flexible cord to the leaflet; coupling a second end of the flexible cord to the tissue anchor; and anchoring the tissue anchor of any one of Examples 1-32 to tissue of a heart.
The foregoing Examples are just that, and should not be read to limit or otherwise narrow the scope of any of the inventive concepts otherwise provided by the instant disclosure. While multiple examples are disclosed, still other embodiments will become apparent to those skilled in the art from the following detailed description, which shows and describes illustrative examples. Accordingly, the drawings and detailed description are to be regarded as illustrative in nature rather than restrictive in nature.
The accompanying drawings are included to provide a further understanding of the disclosure and are incorporated in and constitute a part of this specification, illustrate embodiments, and together with the description serve to explain the principles of the disclosure.
This description is not meant to be read in a restrictive manner. For example, the terminology used in the description should be read broadly in the context of the meaning those in the field would attribute such terminology.
With respect to terminology of inexactitude, the terms “about” and “approximately” may be used, interchangeably, to refer to a measurement that includes the stated measurement and that also includes any measurements that are reasonably close to the stated measurement. Measurements that are reasonably close to the stated measurement deviate from the stated measurement by a reasonably small amount as understood and readily ascertained by individuals having ordinary skill in the relevant arts. Such deviations may be attributable to measurement error, differences in measurement and/or manufacturing equipment calibration, human error in reading and/or setting measurements, minor adjustments made to optimize performance and/or structural parameters in view of differences in measurements associated with other components, particular implementation scenarios, imprecise adjustment and/or manipulation of objects by a person or machine, and/or the like, for example. In the event it is determined that individuals having ordinary skill in the relevant arts would not readily ascertain values for such reasonably small differences, the terms “about” and “approximately” can be understood to mean plus or minus 10% of the stated value.
Certain terminology is used herein for convenience only. For example, words such as “top”, “bottom”, “upper,” “lower,” “left,” “right,” “horizontal,” “vertical,” “upward,” and “downward” merely describe the configuration shown in the figures. Indeed, the referenced components may be oriented in any direction. Similarly, throughout this disclosure, where a process or method is shown or described, the method may be performed in any order or simultaneously, unless it is clear from the context that the method depends on certain actions being performed first.
Persons skilled in the art will readily appreciate that various aspects of the present disclosure can be realized by any number of methods and apparatuses configured to perform the intended functions. It should also be noted that the accompanying drawing figures referred to herein are not necessarily drawn to scale, but may be exaggerated to illustrate various aspects of the present disclosure, and in that regard, the drawing figures should not be construed as limiting.
Applications for the methods, systems, and devices discussed herein may be directed toward providing an artificial chordae that includes a flexible cord. The artificial chordae may be configured to be attached to one or more valve leaflets and/or other heart structures, such as one or more heart wall(s) (e.g., septums or other chamber walls), papillary muscles, or other structures. In some applications, the valve undergoing repair may be the mitral valve or tricuspid valve. In various examples, the flexible cord is coupled at the superior end to one or more leaflets and at the inferior end to the papillary muscle, ventricular wall, or other structure. One or both ends of the flexible cord may include an anchor for coupling the flexible cord between heart structures. Although various embodiments are described in association with chordae tendinea applications, it should be appreciated that it is specifically contemplated that the principles of operation and associated features and concepts are applicable to any tissue anchoring application as desired.
Stretched, ruptured, or broken chordae tendineae 102a-g may alter functionality of the leaflets 110 of the mitral valve. In these instances, for example, the mitral valve may no longer fully coapt or close. As a result, blood can flow from the left ventricle 108 back into the left atrium 106 (e.g., mitral regurgitation).
According to various examples, the flexible cord 202 is biocompatible and may be made of a material, such as, but not limited to, one or more of polypropylene, Nylon (polyimide), polyester, polyvinylidene fluoride or polyvinylidene difluoride (PVDF), silk, or formed of a fluoropolymer, including without limitation, polytetrafluoroethylene (PTFE) or expanded polytetrafluoroethylene (ePTFE), among other suitable materials. The flexible cord 202 may be formed of suture material, including, but not limited to, monofilament sutures, multifilament and/or braided structures, and woven and non-woven materials. In some examples, the flexible cord 202 is made of a fluoropolymer based suture material, such as that associated with GORE-TEX® Sutures for Chordae Tendineae (“CT”) Treatment. Although synthetic materials are contemplated according to various embodiments, in some examples, the flexible cord 202 may also include natural materials, such as, but not limited to, human or other animal tissues or plant-based material.
The first attachment member 204 and the second attachment member 206 are configured to attach the flexible cord 202 tissue of the heart. The first attachment member 204 and the second attachment member 206 may be anchors that pierce the tissue and retain the flexible cord 202 between a first location and a second location with the first attachment member 204 and the second attachment member 206 piercing and retaining at a surface of or within the tissue at, respectively, the first location and the second location. The first attachment member 204 and the second attachment member 206 may include barbs, fixation helixes, hooks, prongs, or any similar structure.
In certain instances, the flexible cord 202 may be used for treating a defective mitral or tricuspid valve. In these such instances, an apical region of a heart is percutaneously accessed with a catheter-based device. The cardiac valve is repaired by replacing at least one chordae tendineae (e.g., as shown in
As referenced, the flexible cord 202 can be supplied with one or more anchors or attachment mechanisms. In some examples, the flexible cord 202 is supplied with one or more pledget anchors, for example made of fluoropolymer, such as ePTFE, or any of the materials described in association with the flexible cord 202. Such pledget anchors can be supplied with pre-punched holes or other features and may be used to anchor to one or more valve leaflets or other heart structures. Such anchors may include hook-, corkscrew-, or barbed-designs, among others. In some examples, the flexible cord 202 is supplied with a self-expanding (e.g., such as, but not limited to nitinol (NiTi)) anchor, as described in detail below, configured to assist with anchoring to a heart structure, such as the papillary or ventricular wall. For example, the anchor may be shaped-set NiTi with several leg members that are displaced from a central tube to resist motion.
The one least one wire 308a, 308b is arranged to form a plurality of anchors 310a-d that extend from the distal end 306 of the tubular member 306 as shown in further detail in
The one least one wire 308a, 308b also may form an eyelet 312. The eyelet extends outward from the proximal end 304. In certain instances, a flexible cord, as described in detail above, may be arranged through the eyelet 312 for chordae tendineae treatment. In certain instances, the one least one wire 308a, 308b are arranged to overlap to form the eyelet 312.
As shown in
In certain instances, and as shown in
In certain instances, the tissue piercing element 316 includes a longitudinal portion 320 and a depth indicator 322 configured to indicate to a physician embedding of the plurality of anchors 310a-d within tissue. The depth indicator 322 may include a spacer, such as a washer, and a biasing member, such as a spring (e.g. as shown in
The first circular portion 424 may be configured to interface with a flexible cord 202, as described in detail above, for chordae tendineae treatment. In addition, the one or more tissue piercing elements 316a, 316b are configured to engage a tissue surface 450 and move between a first configuration, shown in
The intermediate portion 426 is configured to move the one or more tissue piercing elements 316a, 316b from the first configuration to the second configuration in response to a reduction in diameter of the intermediate portion 426. In certain instances, the intermediate portion 426 is substantially oval in shape as shown in
The reduction in diameter of the intermediate portion 426 moves the one or more tissue piercing elements 316a, 316b from the non-engagement configuration (e.g., substantially parallel to a long axis of the intermediate portion 426) to be arranged non-parallel to the tissue surface 450 (e.g., substantially perpendicular to the long axis of the intermediate portion 426) as shown in
In addition, the at least one wire 308 includes a second circular portion 456, as shown in
Each of the plurality of anchors 310a-c includes a substantially linear section 662 extending parallel from the distal end 306 of the cylindrical portion 302 to the longitudinal axis 660. In addition, the plurality of anchors 310a-c includes a curved section 664 extending from the substantially linear section 662. The curved section 664 of each of the plurality of anchors 310a-c may be configured to align with the substantially linear section 662 relative to the longitudinal axis 660 in a delivery configuration, shown in
In certain instances, the cylindrical portion 302 includes one or more notches 668 in an exterior surface of the cylindrical portion. The notches 668 are cut-outs or remove portions of the material of the cylindrical portion 302. The notches 668 may facilitate flexibility of the cylindrical portion 302. In certain instances, the plurality of anchors 310a-c and the cylindrical portion 302 are formed a unitary structure such as a cut-tube. In addition, the cylindrical portion 302 may include an eyelet 312 that may be configured to interface with a flexible cord 202, as described in detail above, for chordae tendineae treatment.
In certain instances, the cylindrical portion 302 also includes a flexible cord pivot 670. The flexible cord 202, as shown in
In certain instances, the tissue anchor 300 may also include an adjustable mechanism 672. As shown in
The tissue anchor 300 may also include a first transition section 754a arranged between and extending perpendicular to the first anchor section 750a and the second anchor section 750b in a first plane. In addition, the tissue anchor 300 may also include a second transition section 754b arranged between and extending perpendicular to the first anchor section 750a and the second anchor section 750b in a second plane. In certain instances, the first plane and the second plane are spaced apart from one another.
In certain instances, the first transition section 754a and the second transition section 754b are parallel to one another. In addition, the first anchor section 750a and the second anchor section 750b may be arranged parallel to one another. Further, at least one of the first transition section 754a and the second transition includes 754b a curvature as is shown in
The tissue anchor 300 includes a plurality of anchors 310a, 310b (although the tissue anchor 300 may include more anchors as shown in
In response to tension, the plurality of anchors 310a, 310b may splay open more. The plurality of anchors 310a, 310b may be configured to secure within tissue. In addition, the flexible cord 202 may be for chordae tendineae treatment. The ball 842 contacting the anchors 310a, 310b may cause the movement of the anchors 310a, 310b.
As shown, the anchor element 310 includes a helical structure having a proximal end 924 arranged at the distal end 306 of the cylindrical portion 302 and including a plurality of loops increasing in diameter from the proximal end of the helical structure to a distal end 926 of the helical structure. The helical structure increasing in diameter may increase surface area engagement of the anchor element 310. In addition, the anchor element 310 (or any anchor element discussed herein) may include one or more barbs 928 arranged on an exterior surface of the helical structure. The barbs 928 may further grip the tissue surface 450 to secure the anchor element 310 therein. The cylindrical portion 302 may be configured to interface with a flexible cord 202, as described in detail above, for chordae tendineae treatment.
In addition, the tissue anchor 300 shown in
In certain instances, the cylindrical portion 302 may be configured to interface with a flexible cord 202, as described in detail above, configured for chordae tendineae treatment.
As shown in
As shown in
The one least one wire 308a, 308b is arranged to form a plurality of anchors 310a-b that extend from the distal end 306 of the tubular member 303.
The tissue anchor 300 also includes a tissue piercing element 316 extending from the tubular member 303. The tissue piercing element 316 may be arranged between the plurality of anchors 310a-b. In certain instance, the tissue piercing element 316 includes a penetrating tip 318. The penetrating tip 318 may also be configured to anchor within tissue. In addition, the penetrating tip 318 may be helical (e.g., as described in further detail below).
In certain instances, the depth indicator 322 is configured to indicate to a physician embedding of the plurality of anchors 310a-d within tissue. The tissue piercing element 316 may be forced into tissue and the depth indicator 322 may provide tactile feedback to a physician. The tissue piercing element 316 be formed of a wire or a portion of a cut-tube or cut-sheet in certain instances. in addition, the tissue piercing element 316 may be substantially linear as shown in
The invention of this application has been described above both generically and with regard to specific embodiments. It will be apparent to those skilled in the art that various modifications and variations can be made in the embodiments without departing from the scope of the disclosure. Thus, it is intended that the embodiments cover the modifications and variations of this invention provided they come within the scope of the appended claims and their equivalents.
This application is a national phase application of PCT Application No. PCT/US2020/052163, internationally filed on Sep. 23, 2020, which claims the benefit of Provisional Application No. 62/904,327, filed Sep. 23, 2019, which are incorporated herein by reference in their entireties for all purposes.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US2020/052163 | 9/23/2020 | WO |
Number | Date | Country | |
---|---|---|---|
62904327 | Sep 2019 | US |